Results 101 to 110 of about 4,624 (210)
Venous Malformations in Childhood: Clinical, Histopathological and Genetics Update [PDF]
Our knowledge in vascular anomalies has grown tremendously in the past decade with the identification of key molecular pathways and genetic mutations that drive the development of vascular tumors and vascular malformations.
Colmenero, Isabel, Knöpfel, Nicole
core
Targeting miR-27a/VE-cadherin interactions rescues cerebral cavernous malformations in mice. [PDF]
Cerebral cavernous malformations (CCMs) are vascular lesions predominantly developing in the central nervous system (CNS), with no effective treatments other than surgery.
Chen J +12 more
core +1 more source
Markov models for clinical decision‐making in radiation oncology: A systematic review
Abstract The intrinsic stochasticity of patients' response to treatment is a major consideration for clinical decision‐making in radiation therapy. Markov models are powerful tools to capture this stochasticity and render effective treatment decisions.
Lucas B McCullum +10 more
wiley +1 more source
Endothelial cell diversity: the many facets of the crystal
Endothelial cells form the inner lining of blood vessels and play crucial roles in angiogenesis. Recent years have seen a surge in the identification of spatiotemporal molecular and functional heterogeneity of ECs. In this review, we highlight many aspects of the diversity of ECs, such as their morphological heterogeneity, the paracrine release of ...
Lorena Perez‐Gutierrez +2 more
wiley +1 more source
Abstract Vascular malformations (VMs) are clinically diverse with regard to the vessel type, anatomical location, tissue involvement and size. Consequently, symptoms and disease impact differ significantly. Diverse causative mutations in more and more genes are discovered and play a major role in the development of VMs.
M. L. E. Stor +6 more
wiley +1 more source
Cerebral cavernous malformation (CCM) pathogenesis involves elevated reactive oxygen species (ROS) levels. REC‐994 restores ROS balance, and in double‐blind, placebo‐controlled, trials in healthy volunteers, had low potential for off‐target adverse effects and pharmacokinetics suitable for phase 2 development.
Ron Alfa +10 more
wiley +1 more source
Angiopoietin-2 predicts morbidity in adults with Fontan physiology. [PDF]
Morbidity in patients with single-ventricle Fontan circulation is common and includes arrhythmias, edema, and pulmonary arteriovenous malformations (PAVM) among others. We sought to identify biomarkers that may predict such complications.
Aboulhosn, Jamil A +8 more
core
Cerebral Cavernous Malformations: An Update on Prevalence, Molecular Genetic Analyses, and Genetic Counselling [PDF]
Based on the latest gnomAD dataset, the prevalence of symptomatic hereditary cerebral cavernous malformations (CCMs) prone to cause epileptic seizures and stroke-like symptoms was re-evaluated in this review and calculated to be 1:5,400-1:6,200 ...
Felbor, Ute +3 more
core +1 more source
FAM222B Is Not a Likely Novel Candidate Gene for Cerebral Cavernous Malformations [PDF]
Cerebral cavernous malformations (CCMs) are prevalent slow-flow vascular lesions which harbour the risk to develop intracranial haemorrhages, focal neurological deficits, and epileptic seizures.
Acker-Palmer, Amparo +12 more
core +1 more source

